Integrative immune-genomic profiling for identification of treatment-relevant phenotypes association with predicted sensitivity to neoadjuvant chemo-immunotherapy in muscle-invasive bladder cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results